Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2024-02-22 AGM Information
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Kallelse till extra bolagsstämma i Abliva AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kallelse till extra bolagsstämma i Abliva AB (publ)" which translates to 'Notice of Extraordinary General Meeting in Abliva AB (publ)'. It details the date, location, registration procedures, agenda items (including proposals for amending the articles of association, rights issue, directed convertible issue, and authorizing future issues), and voting requirements for an upcoming shareholder meeting. This content directly corresponds to the purpose of materials distributed for a General Meeting, specifically an Extraordinary General Meeting (EGM). While it is a notice/call for the meeting, the core subject matter is the meeting itself and the resolutions to be voted upon, which aligns best with the 'AGM Information' category, even though it is an EGM. Since there is no specific code for EGM, AGM-R is the most appropriate fit for General Meeting materials.
2024-02-22 Swedish
Notice of Extraordinary General Meeting of Abliva AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Extraordinary General Meeting of Abliva AB (publ)". It details the date, time, location, registration procedures, proposed agenda items (including amendments to Articles of Association, rights issue, and convertible bonds issue), and resolutions to be voted upon by shareholders. This content perfectly matches the definition of materials prepared for a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While it contains proposals for capital changes (CAP), the primary document type is the formal notice convening the meeting itself, which falls under the scope of AGM/EGM materials. Since AGM-R covers AGM materials, and this is an EGM notice, it is most closely aligned with the general meeting context. However, looking at the provided codes, there is no specific EGM code. AGM-R is for 'Presentations and materials shared during the Annual General Meeting (AGM)'. Since this is a notice for an EGM, and it solicits shareholder votes on resolutions, it is closely related to proxy materials (PSI) or general meeting documentation. Given the options, a notice convening a general meeting where resolutions are proposed is best classified as related to the meeting process. Since the document is the formal notice convening the meeting and detailing the voting items, it is a core component of the shareholder meeting process. If the document were the results, it would be DVA. If it were the proxy statement soliciting votes, it would be PSI. A notice of meeting is often bundled with proxy materials or considered part of the overall AGM/EGM process. Given the strong focus on convening the meeting and listing the resolutions, and lacking a specific EGM code, AGM-R is the closest fit for general meeting documentation, although PSI (Proxy Solicitation & Information Statement) is also highly relevant as this notice serves to inform shareholders ahead of voting. Since the document is the *Notice* itself, and not the full proxy statement soliciting votes (though it contains resolution details), I will lean towards the general meeting context (AGM-R) or the proxy information (PSI). Given the detailed proposals, it functions as an information statement for the meeting. I will select AGM-R as the most encompassing category for formal general meeting documentation when EGM is not specified, as it is a notice convening the meeting.
2024-02-22 English
Styrelsen för Abliva beslutar om en fullt garanterad företrädesemission om 46 MSEK och en riktad emission av konvertibler om 42 MSEK för att förbereda slutfasen av FALCON-studien med KL1333
Capital/Financing Update Classification · 1% confidence The document is a press release from Abliva AB announcing a capital raise consisting of a fully guaranteed rights issue (företrädesemission) of approximately 46 MSEK and a directed issue of convertibles of approximately 42 MSEK. The purpose is to finance the final phase of the FALCON study for KL1333. This clearly details financing activities, capital structure changes (issuance of new shares/convertibles), and associated terms (subscription price, dates, shareholder approval required). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Since it is a detailed announcement about the financing structure, it is classified as CAP rather than the general fallback (RNS).
2024-02-22 Swedish
The Board of Directors of Abliva resolves on a fully guaranteed rights issue of SEK 46 million and a directed issue of convertible bonds of SEK 42 million to prepare for the final stage of the FALCON
Capital/Financing Update Classification · 1% confidence The document explicitly details a proposed 'rights issue' of SEK 46 million and a 'directed issue of convertible bonds' of SEK 42 million, totaling an SEK 88 million capital raise. It discusses subscription prices, record dates, subscription periods, and the need for approval by an Extraordinary General Meeting (EGM). These elements are characteristic of announcements related to fundraising, capital structure changes, and financing activities. This aligns directly with the definition for Capital/Financing Update (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV).
2024-02-22 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is a 'Kvartalsrapport' (Quarterly Report) for the period January-September 2023. It contains comprehensive financial data (income statements, earnings per share), management commentary on business trends (FALCON study progress, Fast Track status, licensing agreements), and strategic outlook. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2023
2023-11-17 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report' and covers the period 'January - September 2023'. It contains detailed financial information, including net revenues, loss before tax, and loss per share for both the third quarter and the nine-month period. It also includes management commentary on clinical trials (FALCON study), strategic focus, and business updates. As it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2023
2023-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.